Clinical Decision Support Systems Market
Research Code:MRHC - 104248
Sku:MRHC - 104248
Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive), and Settings - Global Forecasts to 2024
- Report ID: MRHC - 104248
- Pages: 117
- Apr-2019
- Formats*: PDF
- Category: Healthcare
- Delivery: 24 to 72 Hours
The key factors driving the growth of Clinical Decision Support System (CDSS) market are increasing incidence of medical errors, increasing adoption of mhealth tools & big data, value-based reimbursements, and increasing government initiatives and corporate investments. Moreover, increasing adoption of cloud computing in healthcare as well as emerging economies offer significant growth opportunities for CDSS market players. In recent years, this market has witnessed significant rise in collaborations/partnerships between CDSS companies and hospitals to develop and provide software updated with latest information. Another major trend observed in the market is integration of CDSS with Electronic Health Record (EHR).
The major factors fueling the growth of CDSS market include increasing adoption of EHRs, rising importance and usage of big data and mhealth tools, growing incidence of medication errors, increasing adoption of cloud computing in healthcare, government support, and technological advancements.
Click here to : Get Free Sample Pages of this Report
According to the National Institutes of Health, medical errors are most common at the ordering or prescribing stage. The Food and Drug Administration estimated that 1.3 million people are affected by medication errors annually in the U.S. In addition, medical errors cause approximately 2,50,000 deaths in the U.S. per year and is the third leading cause of death in the country. As CDSS aids healthcare providers in effective clinical-decision making, growing incidence of medical errors is expected to drive the adoption of CDSS during the forecast period.
The clinical decision support systems market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2024 - by component, product, type, model, delivery mode, application, level of interactivity, and settings. The study also evaluates industry competitors and analyzes the market at regional and country level.
On the basis of component, services commanded the largest share of clinical decision support systems market in 2017, owing to the frequent nature of services such as training and development, installation, consulting, and maintenance. However, due to the need for episodic or periodic software upgradation and growing demand of CDSS, the software segment is expected to witness the highest growth during the forecast period.
Based on product, the CDSS market is segmented into integrated and standalone systems. Integrated CDSS segment accounted for the largest share in 2017 and is also expected to witness the highest growth during the forecast period. The large share and high growth of the segment can be attributed to its ability to provide a robust database to support evidence-based clinical decision-making.
The report includes extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2015-2018). For instance, in 2017, Change Healthcare launched the new version of InterQual clinical decision support system, which consist of Medicare Procedures with efficient set of criteria, review, and other features that better help decision-making. Similarly, in July 2018, Guerbet collaborated with IBM Watson Health to help support clinical decisions.
The major players being studied under these study are Wolters Kluwer Health (U.S.), Hearst Health (U.S.), and Elsevier B.V. (The Netherlands), Cerner Corporation (U.S.), McKesson Corporation (Change Healthcare) (U.S.), Epic Systems Corporation (U.S.), MEDITECH (U.S.), Philips Healthcare (The Netherlands), International Business Machines (IBM) (U.S.), and Allscripts Healthcare Solutions, Inc. (U.S.).
Key questions answered in the report:
Increasing adoption of EHRs and increasing incidence of medical errors fuel the growth of global clinical decision support systems market
- How does the penetration of clinical decision support systems in conventional application differ from the advanced application?
- Which are the high growth market segments in terms of component, product, type, model, delivery mode, application, level of interactivity, settings, and regions/countries?
Services commanded the largest share of the overall clinical decision support systems market in 2017
- What are the key trends in the adoption of CDSS services market?
- How does the penetration of CDS system service differs from other components of the system?
The North American clinical decision support systems market favors both larger and local manufacturers that compete in multiple segments
- Who are the top competitors in this market and what strategies do they employ to gain shares?
- What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
- What strategies should new companies looking to enter this market to compete effectively?
- What are the major drivers, restrains, challenges, and opportunities in the clinical decision support systems market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the geographical trends and high growth regions/ countries?
Recent new approvals, collaborations, partnerships, and agreements, new product launches, and expansions taken place in the clinical decision support systems market space
- What companies have recently entered into partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the clinical decision support systems market space?
- Which companies have recently received approvals and how will these approvals promote a competitive advantage?
- Who are the local emerging players in the clinical decision support systems market and how do they compete with the global players?
1 Introduction
1.1 Market Definition
1.2 Market Scope
1.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
3 Executive Summary
4 Market Insights
4.1 Introduction
4.2 Market Drivers
4.2.1 Increasing adoption of EHRs
4.2.2 Government Support and Initiatives
4.2.3 Growing Incidence of Medication Errors
4.2.4 Rising Importance and Usage of Big Data and mhealth Tools
4.2.5 Increasing Partnerships Between Medical Research Groups and Clinical Decision Support
Companies
4.2.6 Rapid Growth in the Geriatric Population and High Prevalence of Chronic Diseases
4.3 Restraints
4.3.1 Data Security Concerns Related to Cloud-Based CDSS
4.3.2 Lack of Interoperability
4.3.3 Reluctance to Adopt Mobile CDSS
4.4 Opportunities
4.4.1 Emerging Economies
4.4.2 Cloud-based CDSS
4.5 Challenges
4.5.1 Lack of Skilled IT Professionals in the Healthcare Industry
4.5.2 Integration of CDSS Solutions Within Healthcare Organizations
5 Clinical Decision Support Systems Market, by Component
5.1 Introduction
5.2 Services
5.3 Software
5.4 Hardware
6 Clinical Decision Support Systems Market, by Product
6.1 Introduction
6.2 Integrated CDSS
6.3 Standalone CDSS
7 Clinical Decision Support Systems Market, by Type
7.1 Introduction
7.2 Therapeutic CDSS
7.3 Diagnostic CDSS
8 Clinical Decision Support Systems Market, by Model
8.1 Introduction
8.2 Knowledge-Based CDSS
8.3 Non-Knowledge-Based CDSS
9 Clinical Decision Support Systems Market, by Delivery Mode
9.1 Introduction
9.2 On-Premise CDSS
9.3 Cloud-Based CDSS
10 Clinical Decision Support Systems Market, by Application
10.1 Introduction
10.2 Conventional CDSS
10.2.1 Drug-drug interactions
10.2.2 Drug allergy alerts
10.2.3 Drug dosing support
10.2.4 Clinical reminders
10.2.5 Clinical guidelines
10.2.6 Others
10.3 Advanced CDSS
11 Clinical Decision Support Systems Market, by Level of Interactivity
11.1 Introduction
11.2 Active CDSS
11.3 Passive CDSS
12 Clinical Decision Support Systems Market, by Settings
12.1 Introduction
12.2 Inpatient Settings
12.3 Ambulatory Care Settings
13 Clinical Decision Support Systems Market, by Geography
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.3 Europe
13.3.1 Germany
13.3.2 U.K.
13.3.3 France
13.3.4 Spain
13.3.5 Italy
13.3.6 RoE
13.4 Asia-Pacific
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 RoAPAC
13.5 RoW
14 Competitive Landscape
14.1 Introduction
14.2 Competitive Benchmarking
14.3 Market share analysis, by Key Players
15 Company Profiles
15.1 Allscripts Healthcare Solutions, Inc.
15.1.1 Business Overview
15.1.2 Financial Overview
15.1.3 Product Portfolio
15.1.4 Strategic Developments
15.2 Cerner Corporation
15.2.1 Business Overview
15.2.2 Financial Overview
15.2.3 Product Portfolio
15.2.4 Strategic Developments
15.3 Elsevier B.V. (A Division of Relx Group)
15.3.1 Business Overview
15.3.2 Financial Overview
15.3.3 Product Portfolio
15.3.4 Strategic Developments
15.4 Epic Systems
15.4.1 Business Overview
15.4.2 Financial Overview
15.4.3 Product Portfolio
15.4.4 Strategic Developments
15.5 Hearst Health
15.5.1 Business Overview
15.5.2 Financial Overview
15.5.3 Product Portfolio
15.5.4 Strategic Developments
15.6 IBM
15.6.1 Business Overview
15.6.2 Financial Overview
15.6.3 Product Portfolio
15.6.4 Strategic Developments
15.7 MEDITECH
15.7.1 Business Overview
15.7.2 Financial Overview
15.7.3 Product Portfolio
15.7.4 Strategic Developments
15.8 McKesson Corporation (Change Healthcare)
15.8.1 Business Overview
15.8.2 Financial Overview
15.8.3 Product Portfolio
15.8.4 Strategic Developments
15.9 Philips Healthcare (A Subsidiary of Royal Philips Electronics)
15.9.1 Business Overview
15.9.2 Financial Overview
15.9.3 Product Portfolio
15.9.4 Strategic Developments
15.10 Wolters Kluwer Health
15.10.1 Business Overview
15.10.2 Financial Overview
15.10.3 Product Portfolio
15.10.4 Strategic Developments
16 Appendix
16.1 Questionnaire
16.2 Available Customization
This website is secure and we do not share your personal information with any third party. Privacy Policy
The key factors driving the growth of Clinical Decision Support System (CDSS) market are increasing incidence of medical errors, increasing adoption of mhealth tools & big data, value-based reimbursements, and increasing government initiatives and corporate investments. Moreover, increasing adoption of cloud computing in healthcare as well as emerging economies offer significant growth opportunities for CDSS market players. In recent years, this market has witnessed significant rise in collaborations/partnerships between CDSS companies and hospitals to develop and provide software updated with latest information. Another major trend observed in the market is integration of CDSS with Electronic Health Record (EHR).
The major factors fueling the growth of CDSS market include increasing adoption of EHRs, rising importance and usage of big data and mhealth tools, growing incidence of medication errors, increasing adoption of cloud computing in healthcare, government support, and technological advancements.
Click here to : Get Free Sample Pages of this Report
According to the National Institutes of Health, medical errors are most common at the ordering or prescribing stage. The Food and Drug Administration estimated that 1.3 million people are affected by medication errors annually in the U.S. In addition, medical errors cause approximately 2,50,000 deaths in the U.S. per year and is the third leading cause of death in the country. As CDSS aids healthcare providers in effective clinical-decision making, growing incidence of medical errors is expected to drive the adoption of CDSS during the forecast period.
The clinical decision support systems market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2024 - by component, product, type, model, delivery mode, application, level of interactivity, and settings. The study also evaluates industry competitors and analyzes the market at regional and country level.
On the basis of component, services commanded the largest share of clinical decision support systems market in 2017, owing to the frequent nature of services such as training and development, installation, consulting, and maintenance. However, due to the need for episodic or periodic software upgradation and growing demand of CDSS, the software segment is expected to witness the highest growth during the forecast period.
Based on product, the CDSS market is segmented into integrated and standalone systems. Integrated CDSS segment accounted for the largest share in 2017 and is also expected to witness the highest growth during the forecast period. The large share and high growth of the segment can be attributed to its ability to provide a robust database to support evidence-based clinical decision-making.
The report includes extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2015-2018). For instance, in 2017, Change Healthcare launched the new version of InterQual clinical decision support system, which consist of Medicare Procedures with efficient set of criteria, review, and other features that better help decision-making. Similarly, in July 2018, Guerbet collaborated with IBM Watson Health to help support clinical decisions.
The major players being studied under these study are Wolters Kluwer Health (U.S.), Hearst Health (U.S.), and Elsevier B.V. (The Netherlands), Cerner Corporation (U.S.), McKesson Corporation (Change Healthcare) (U.S.), Epic Systems Corporation (U.S.), MEDITECH (U.S.), Philips Healthcare (The Netherlands), International Business Machines (IBM) (U.S.), and Allscripts Healthcare Solutions, Inc. (U.S.).
Key questions answered in the report:
Increasing adoption of EHRs and increasing incidence of medical errors fuel the growth of global clinical decision support systems market
- How does the penetration of clinical decision support systems in conventional application differ from the advanced application?
- Which are the high growth market segments in terms of component, product, type, model, delivery mode, application, level of interactivity, settings, and regions/countries?
Services commanded the largest share of the overall clinical decision support systems market in 2017
- What are the key trends in the adoption of CDSS services market?
- How does the penetration of CDS system service differs from other components of the system?
The North American clinical decision support systems market favors both larger and local manufacturers that compete in multiple segments
- Who are the top competitors in this market and what strategies do they employ to gain shares?
- What is driving the growth and which market segments have the most potential for revenue expansion over the forecast period?
- What strategies should new companies looking to enter this market to compete effectively?
- What are the major drivers, restrains, challenges, and opportunities in the clinical decision support systems market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the geographical trends and high growth regions/ countries?
Recent new approvals, collaborations, partnerships, and agreements, new product launches, and expansions taken place in the clinical decision support systems market space
- What companies have recently entered into partnerships/collaborations/agreements and how will these unions affect the competitive landscape of the clinical decision support systems market space?
- Which companies have recently received approvals and how will these approvals promote a competitive advantage?
- Who are the local emerging players in the clinical decision support systems market and how do they compete with the global players?
1 Introduction
1.1 Market Definition
1.2 Market Scope
1.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
3 Executive Summary
4 Market Insights
4.1 Introduction
4.2 Market Drivers
4.2.1 Increasing adoption of EHRs
4.2.2 Government Support and Initiatives
4.2.3 Growing Incidence of Medication Errors
4.2.4 Rising Importance and Usage of Big Data and mhealth Tools
4.2.5 Increasing Partnerships Between Medical Research Groups and Clinical Decision Support
Companies
4.2.6 Rapid Growth in the Geriatric Population and High Prevalence of Chronic Diseases
4.3 Restraints
4.3.1 Data Security Concerns Related to Cloud-Based CDSS
4.3.2 Lack of Interoperability
4.3.3 Reluctance to Adopt Mobile CDSS
4.4 Opportunities
4.4.1 Emerging Economies
4.4.2 Cloud-based CDSS
4.5 Challenges
4.5.1 Lack of Skilled IT Professionals in the Healthcare Industry
4.5.2 Integration of CDSS Solutions Within Healthcare Organizations
5 Clinical Decision Support Systems Market, by Component
5.1 Introduction
5.2 Services
5.3 Software
5.4 Hardware
6 Clinical Decision Support Systems Market, by Product
6.1 Introduction
6.2 Integrated CDSS
6.3 Standalone CDSS
7 Clinical Decision Support Systems Market, by Type
7.1 Introduction
7.2 Therapeutic CDSS
7.3 Diagnostic CDSS
8 Clinical Decision Support Systems Market, by Model
8.1 Introduction
8.2 Knowledge-Based CDSS
8.3 Non-Knowledge-Based CDSS
9 Clinical Decision Support Systems Market, by Delivery Mode
9.1 Introduction
9.2 On-Premise CDSS
9.3 Cloud-Based CDSS
10 Clinical Decision Support Systems Market, by Application
10.1 Introduction
10.2 Conventional CDSS
10.2.1 Drug-drug interactions
10.2.2 Drug allergy alerts
10.2.3 Drug dosing support
10.2.4 Clinical reminders
10.2.5 Clinical guidelines
10.2.6 Others
10.3 Advanced CDSS
11 Clinical Decision Support Systems Market, by Level of Interactivity
11.1 Introduction
11.2 Active CDSS
11.3 Passive CDSS
12 Clinical Decision Support Systems Market, by Settings
12.1 Introduction
12.2 Inpatient Settings
12.3 Ambulatory Care Settings
13 Clinical Decision Support Systems Market, by Geography
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.3 Europe
13.3.1 Germany
13.3.2 U.K.
13.3.3 France
13.3.4 Spain
13.3.5 Italy
13.3.6 RoE
13.4 Asia-Pacific
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 RoAPAC
13.5 RoW
14 Competitive Landscape
14.1 Introduction
14.2 Competitive Benchmarking
14.3 Market share analysis, by Key Players
15 Company Profiles
15.1 Allscripts Healthcare Solutions, Inc.
15.1.1 Business Overview
15.1.2 Financial Overview
15.1.3 Product Portfolio
15.1.4 Strategic Developments
15.2 Cerner Corporation
15.2.1 Business Overview
15.2.2 Financial Overview
15.2.3 Product Portfolio
15.2.4 Strategic Developments
15.3 Elsevier B.V. (A Division of Relx Group)
15.3.1 Business Overview
15.3.2 Financial Overview
15.3.3 Product Portfolio
15.3.4 Strategic Developments
15.4 Epic Systems
15.4.1 Business Overview
15.4.2 Financial Overview
15.4.3 Product Portfolio
15.4.4 Strategic Developments
15.5 Hearst Health
15.5.1 Business Overview
15.5.2 Financial Overview
15.5.3 Product Portfolio
15.5.4 Strategic Developments
15.6 IBM
15.6.1 Business Overview
15.6.2 Financial Overview
15.6.3 Product Portfolio
15.6.4 Strategic Developments
15.7 MEDITECH
15.7.1 Business Overview
15.7.2 Financial Overview
15.7.3 Product Portfolio
15.7.4 Strategic Developments
15.8 McKesson Corporation (Change Healthcare)
15.8.1 Business Overview
15.8.2 Financial Overview
15.8.3 Product Portfolio
15.8.4 Strategic Developments
15.9 Philips Healthcare (A Subsidiary of Royal Philips Electronics)
15.9.1 Business Overview
15.9.2 Financial Overview
15.9.3 Product Portfolio
15.9.4 Strategic Developments
15.10 Wolters Kluwer Health
15.10.1 Business Overview
15.10.2 Financial Overview
15.10.3 Product Portfolio
15.10.4 Strategic Developments
16 Appendix
16.1 Questionnaire
16.2 Available Customization
1 Introduction
1.1 Market Definition
1.2 Market Scope
1.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
3 Executive Summary
4 Market Insights
4.1 Introduction
4.2 Market Drivers
4.2.1 Increasing adoption of EHRs
4.2.2 Government Support and Initiatives
4.2.3 Growing Incidence of Medication Errors
4.2.4 Rising Importance and Usage of Big Data and mhealth Tools
4.2.5 Increasing Partnerships Between Medical Research Groups and Clinical Decision Support
Companies
4.2.6 Rapid Growth in the Geriatric Population and High Prevalence of Chronic Diseases
4.3 Restraints
4.3.1 Data Security Concerns Related to Cloud-Based CDSS
4.3.2 Lack of Interoperability
4.3.3 Reluctance to Adopt Mobile CDSS
4.4 Opportunities
4.4.1 Emerging Economies
4.4.2 Cloud-based CDSS
4.5 Challenges
4.5.1 Lack of Skilled IT Professionals in the Healthcare Industry
4.5.2 Integration of CDSS Solutions Within Healthcare Organizations
5 Clinical Decision Support Systems Market, by Component
5.1 Introduction
5.2 Services
5.3 Software
5.4 Hardware
6 Clinical Decision Support Systems Market, by Product
6.1 Introduction
6.2 Integrated CDSS
6.3 Standalone CDSS
7 Clinical Decision Support Systems Market, by Type
7.1 Introduction
7.2 Therapeutic CDSS
7.3 Diagnostic CDSS
8 Clinical Decision Support Systems Market, by Model
8.1 Introduction
8.2 Knowledge-Based CDSS
8.3 Non-Knowledge-Based CDSS
9 Clinical Decision Support Systems Market, by Delivery Mode
9.1 Introduction
9.2 On-Premise CDSS
9.3 Cloud-Based CDSS
10 Clinical Decision Support Systems Market, by Application
10.1 Introduction
10.2 Conventional CDSS
10.2.1 Drug-drug interactions
10.2.2 Drug allergy alerts
10.2.3 Drug dosing support
10.2.4 Clinical reminders
10.2.5 Clinical guidelines
10.2.6 Others
10.3 Advanced CDSS
11 Clinical Decision Support Systems Market, by Level of Interactivity
11.1 Introduction
11.2 Active CDSS
11.3 Passive CDSS
12 Clinical Decision Support Systems Market, by Settings
12.1 Introduction
12.2 Inpatient Settings
12.3 Ambulatory Care Settings
13 Clinical Decision Support Systems Market, by Geography
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.3 Europe
13.3.1 Germany
13.3.2 U.K.
13.3.3 France
13.3.4 Spain
13.3.5 Italy
13.3.6 RoE
13.4 Asia-Pacific
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 RoAPAC
13.5 RoW
14 Competitive Landscape
14.1 Introduction
14.2 Competitive Benchmarking
14.3 Market share analysis, by Key Players
15 Company Profiles
15.1 Allscripts Healthcare Solutions, Inc.
15.1.1 Business Overview
15.1.2 Financial Overview
15.1.3 Product Portfolio
15.1.4 Strategic Developments
15.2 Cerner Corporation
15.2.1 Business Overview
15.2.2 Financial Overview
15.2.3 Product Portfolio
15.2.4 Strategic Developments
15.3 Elsevier B.V. (A Division of Relx Group)
15.3.1 Business Overview
15.3.2 Financial Overview
15.3.3 Product Portfolio
15.3.4 Strategic Developments
15.4 Epic Systems
15.4.1 Business Overview
15.4.2 Financial Overview
15.4.3 Product Portfolio
15.4.4 Strategic Developments
15.5 Hearst Health
15.5.1 Business Overview
15.5.2 Financial Overview
15.5.3 Product Portfolio
15.5.4 Strategic Developments
15.6 IBM
15.6.1 Business Overview
15.6.2 Financial Overview
15.6.3 Product Portfolio
15.6.4 Strategic Developments
15.7 MEDITECH
15.7.1 Business Overview
15.7.2 Financial Overview
15.7.3 Product Portfolio
15.7.4 Strategic Developments
15.8 McKesson Corporation (Change Healthcare)
15.8.1 Business Overview
15.8.2 Financial Overview
15.8.3 Product Portfolio
15.8.4 Strategic Developments
15.9 Philips Healthcare (A Subsidiary of Royal Philips Electronics)
15.9.1 Business Overview
15.9.2 Financial Overview
15.9.3 Product Portfolio
15.9.4 Strategic Developments
15.10 Wolters Kluwer Health
15.10.1 Business Overview
15.10.2 Financial Overview
15.10.3 Product Portfolio
15.10.4 Strategic Developments
16 Appendix
16.1 Questionnaire
16.2 Available Customization